StockLogistics
1 year ago
Too much debt too many shares :
“As of September 30, 2022, current assets were $355 million, including cash and cash equivalents of $130 million. The Company had working capital of $85 million and senior secured term loan debt, net of discount and issuance costs, of $380 million.Total shares on a fully converted basis were 437,484,245 as of September 30, 2022.”
Ronin
2 years ago
Which bill? Which committee?
I just read where Schumer's bill got shot down in Senate but they have another in the wings before the upcoming election that has bipartisan agreement to allow pharmas to expand research on marijuana
https://www.marijuanamoment.net/schumer-touts-senate-marijuana-research-bill-among-historic-progress-under-biden-as-legalization-measure-lingers/
According to Sen. Cory Booker (D-NJ), a prime sponsor of CAOA, recently said that the so-called “SAFE Banking Plus” bill that’s in the works would likely be filed following the elections during the lame duck session.
In the meantime, Senate Democrats have the bipartisan marijuana research bill as the main example of cannabis reform progress since President Joe Biden took office and Democrats reclaimed the majority in the Senate.
That specific legislation hasn’t been enacted into law, though. But there are hopes that a slightly revised version that was introduced last month could reach the president’s desk in due time. It already cleared the House just days after its filing, and sources say the Senate is expected to act shortly.
FUNMAN
2 years ago
Cresco Labs to Hold Second Quarter 2022 Earnings Conference Call on August 17, 2022
STOCKS Aug 2, 2022 • 6:30 AM EDT
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the second quarter ended June 30th, 2022, on Wednesday, August 17th, 2022, before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Second Quarter 2022 Earnings Conference Call
Date: Wednesday, August 17th, 2022
Time: 8:30am EST
Webcast: Link
Dial-in: 1-844-200-6205 (US Toll Free), 1-833-950-0062 (Canada Toll Free), 1-646-904-5544 (US Local), +1 929-526-1599 (Other)
Access Code: 035060
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220801005267/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com
Investors:
investors@crescolabs.com
For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs Inc.
Nelson2
2 years ago
Here you go boyz!
“First Quarter 2022 Financial Highlights
First quarter revenue of $214 million, up 20% year-over-year
Gross profit excluding fair value mark-up for acquired inventory of $113 million, or 53% of revenue, an increase of 29% year-over-year
First quarter adjusted EBITDA1 of $51 million, or 24% of revenue, an increase of 45% year-over-year
Wholesale revenue of $95 million, maintained position as #1 seller of branded cannabis products in U.S. with leading share in the flower, concentrates, and vape categories
Retail revenue increased 44% year-over-year, to $119 million, or $2.5 million per average store open in the quarter and same-store-sales increased 9% year-over-year
Ended the quarter with $179 million of cash on hand
Opened four new retail stores, three in Florida and one in Pennsylvania, bringing the Company’s total retail footprint to 50
Launched branded product portfolio in Florida, including High Supply®, Good News®, Remedi™ and Sunnyside* Chews”